Severe Bullous Skin Eruptions on Checkpoint Inhibitor Therapy - in Most Cases Severe Bullous Lichenoid Drug Eruptions
Overview
Affiliations
Ziemer M, Livingstone E Pathologie (Heidelb). 2025; 46(2):90-100.
PMID: 39964515 DOI: 10.1007/s00292-025-01418-w.
Update on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management.
Shah H, Parisi R, Mukherjee E, Phillips E, Dodiuk-Gad R Am J Clin Dermatol. 2024; 25(6):891-908.
PMID: 39278968 PMC: 11511757. DOI: 10.1007/s40257-024-00889-6.
Immune checkpoint inhibitor associated epidermal necrosis, beyond SJS and TEN: a review of 98 cases.
Bray E, Lin R, Li J, Elgart G, Elman S, Maderal A Arch Dermatol Res. 2024; 316(6):233.
PMID: 38795205 DOI: 10.1007/s00403-024-03061-6.
Severe cutaneous adverse reactions.
Hung S, Mockenhaupt M, Blumenthal K, Abe R, Ueta M, Ingen-Housz-Oro S Nat Rev Dis Primers. 2024; 10(1):30.
PMID: 38664435 DOI: 10.1038/s41572-024-00514-0.
Reschke R, Deitert B, Enk A, Hassel J Front Immunol. 2024; 15:1385781.
PMID: 38562921 PMC: 10982392. DOI: 10.3389/fimmu.2024.1385781.